Tandem Diabetes Care, Inc.
Tandem Diabetes Care designs, develops, and commercializes technology solutions for people with diabetes. The companys flagship products are the t:slim X2 insulin delivery system and Tandem Mobi insulin pump. It also sells single-use products like cartridges and infusion sets. Additionally, the company offers software updates, a data management platform called Tandem Source, and a mobile app called Sugarmate.
Overview
Strengths
- Pricing power: gross margin has held between 49% and 54% over the last 6 years (latest 53.8%).
- Consistent growth: revenue has compounded at 15.3% a year over 5 years, rising in 4 of them.
Weaknesses
- No sign of a competitive advantage: return on invested capital (latest 0.0%) has been below its cost of capital of 9.1% in 5 of the last 6 years.
- Operating profit does not cover interest expense.
- Our discounted cash flow model finds no value to support the current price: operating profit does not cover interest expense.
- Currently loss-making: the latest fiscal year closed with a net loss.
- Unreliable cash generation: free cash flow was negative in 3 of the last 6 years.
- Unstable profitability: operating margin ranged from -31% to 3% over the last 6 years, with operating losses in 5 of them.
Key Financial Data